PuSH - Publikationsserver des Helmholtz Zentrums München

Walch, O.* ; Rogers, A.* ; Huang, Y.P.* ; Ruben, M.D.* ; Dyar, K.A. ; Flynn, R.W.V.* ; Mackenzie, I.S.* ; Manfredini, R.* ; Cappuccio, F.P.* ; Pigazzani, F.*

Design considerations for hypertension chronotherapy trials: Insights from experience and modelling.

BMC Med. 24:391 (2026)
Verlagsversion Forschungsdaten DOI
Open Access Gold
Creative Commons Lizenzvertrag
Chronotherapy aims to maximise treatment efficacy while minimising side effects by scheduling treatment according to personal biological rhythms. In recent years, randomised clinical trials (RCTs) have been conducted to evaluate whether scheduled blood pressure interventions can improve patient outcomes. However, reports of time-of-day effects have attracted rebuttals and engendered methodological debate. A perfectly controlled chronotherapy trial (i.e., a trial that assesses the effect of assigning time of intervention) will never be feasible in the real world; yet some factors may be more critical to consider and control for than others. To advance the conversation about how best to evaluate the effects of antihypertensive chronotherapeutic interventions in RCTs, we discuss critical considerations for clinical trials of chronotherapy for hypertension and apply mathematical modelling to provide quantitative insights into the extent to which such factors may influence the detected effect size.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Chronotherapy ; Chronotherapy Trial ; Chronotype ; Dosing Time ; Hypertension ; Mathematical Modelling ; Randomised Clinical Trials ; Trial Design; Antihypertensive Drugs; Time; Pharmacokinetics
ISSN (print) / ISBN 1741-7015
e-ISSN 1741-7015
Zeitschrift BMC Medicine
Quellenangaben Band: 24, Heft: 1, Seiten: , Artikelnummer: 391 Supplement: ,
Verlag Springer
Verlagsort Campus, 4 Crinan St, London N1 9xw, England
Begutachtungsstatus Peer reviewed